Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

225 trials with published results (19%)

Research Maturity

753 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.7%

56 terminated out of 1204 trials

Success Rate

93.1%

+6.5% vs benchmark

Late-Stage Pipeline

9%

110 trials in Phase 3/4

Results Transparency

30%

225 of 753 completed with results

Key Signals

225 with results93% success56 terminated

Data Visualizations

Phase Distribution

949Total
Not Applicable (581)
Early P 1 (25)
P 1 (110)
P 2 (123)
P 3 (57)
P 4 (53)

Trial Status

Completed753
Recruiting134
Unknown106
Terminated56
Active Not Recruiting51
Withdrawn48

Trial Success Rate

93.1%

Benchmark: 86.6%

Based on 753 completed trials

Clinical Trials (1204)

Showing 20 of 20 trials
NCT07848204Phase 1Completed

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

NCT05463289Not ApplicableRecruitingPrimary

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

NCT05944731Not ApplicableSuspendedPrimary

Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya.

NCT07039617Not ApplicableActive Not RecruitingPrimary

A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)

NCT05264376Not ApplicableCompleted

Eating Disorder Prevention Program for Women With T1D

NCT06014879Not ApplicableActive Not RecruitingPrimary

EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes

NCT04572009Not ApplicableCompletedPrimary

Validation of a Biomathematical Model to Help Identify the Parameters of Flexible Insulin Therapy

NCT06783309Phase 1Recruiting

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

NCT07593625Not ApplicableRecruitingPrimary

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D

NCT06273631Not ApplicableRecruitingPrimary

Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes

NCT05791201Phase 1Active Not RecruitingPrimary

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

NCT05153070Phase 2RecruitingPrimary

Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes

NCT05540704Not ApplicableRecruitingPrimary

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

NCT07808385Not ApplicableNot Yet RecruitingPrimary

Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

NCT07807280Not ApplicableRecruitingPrimary

C-Carbs: A CGM-guided Approach to Teaching Carb Awareness

NCT06948760Not ApplicableCompletedPrimary

Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

NCT06891898RecruitingPrimary

The iLet Experience Study

NCT06984185RecruitingPrimary

Early Detection of Type 1 Diabetes

NCT07498738Not ApplicableRecruitingPrimary

Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions

NCT07061574Phase 1RecruitingPrimary

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Scroll to load more

Research Network

Activity Timeline